Anúncio
Anúncio

AKTX

AKTX logo

Akari Therapeutics plc ADR (0.01 USD)

0.29
USD
Patrocinado
+0.01
+2.34%
09 de jan., 13:47 UTC -5
Abrir

Relatórios de Lucros AKTX

Rácio de surpresa positiva

AKTX separação 8 de 17 últimas estimativas.

47%

Próximo Relatório

Data do Próximo Relatório
13 de abr. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.06
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
--

Akari Therapeutics plc ADR (0.01 USD) earnings per share and revenue

On 13 de nov. de 2025, AKTX reported earnings of 0.00 USD per share (EPS) for Q3 25, beating the estimate of -0.07 USD, resulting in a 100.00% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.67% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -0.06 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Akari Therapeutics plc ADR (0.01 USD) reported EPS of $0.00, beating estimates by 100%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.67%, changed from $0.52 before the earnings release to $0.53 the day after.
The next earning report is scheduled for 13 de abr. de 2026.
Based on 5 analistas, Akari Therapeutics plc ADR (0.01 USD) is expected to report EPS of -$0.06 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio